Biosecurity enhancement through pathophysiologically appropriate models of epithelial infection: enabling anti-viral and immunisation therapeutic and preventative developments (Project 1.4 under ARC CPTT)

Grant number: IC170100016 | Funding period: 2018 - 2022

Active

Abstract

The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries. By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therapeutics. The use of an individual patient’s cellular and molecular research findings will ultimately enable personalised diagnostic and therapeutic decisions.